These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 27794450)

  • 21. Enhanced Hepatic Functions of Genetically Modified Mouse Hepatoma Cells by Spheroid Culture for Drug Toxicity Screening.
    Sarkar J; Kumari J; Tonello JM; Kamihira M; Kumar A
    Biotechnol J; 2017 Oct; 12(10):. PubMed ID: 28834334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic Modifications of the Liver Tumor Cell Line HepG2 Increase Their Drug Metabolic Capacity.
    Ruoß M; Damm G; Vosough M; Ehret L; Grom-Baumgarten C; Petkov M; Naddalin S; Ladurner R; Seehofer D; Nussler A; Sajadian S
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30654452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fasudil and viscosity of gelatin promote hepatic differentiation by regulating organelles in human umbilical cord matrix-mesenchymal stem cells.
    Choi J; Kang S; An HI; Kim CE; Lee S; Pack CG; Yoon YI; Jin H; Cho YP; Kim CJ; Namgoong JM; Kim JK; Tak E
    Stem Cell Res Ther; 2024 Jul; 15(1):229. PubMed ID: 39075621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term chronic toxicity testing using human pluripotent stem cell-derived hepatocytes.
    Holmgren G; Sjögren AK; Barragan I; Sabirsh A; Sartipy P; Synnergren J; Björquist P; Ingelman-Sundberg M; Andersson TB; Edsbagge J
    Drug Metab Dispos; 2014 Sep; 42(9):1401-6. PubMed ID: 24980256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Hepatic 2D Sandwich Cultures and 3D Spheroids for Long-term Toxicity Applications: A Multicenter Study.
    Bell CC; Dankers ACA; Lauschke VM; Sison-Young R; Jenkins R; Rowe C; Goldring CE; Park K; Regan SL; Walker T; Schofield C; Baze A; Foster AJ; Williams DP; van de Ven AWM; Jacobs F; Houdt JV; Lähteenmäki T; Snoeys J; Juhila S; Richert L; Ingelman-Sundberg M
    Toxicol Sci; 2018 Apr; 162(2):655-666. PubMed ID: 29329425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteomic Comparison of Various Hepatic Cell Cultures for Preclinical Safety Pharmacology.
    Hurrell T; Segeritz CP; Vallier L; Lilley KS; Cromarty AD
    Toxicol Sci; 2018 Jul; 164(1):229-239. PubMed ID: 29635369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancing the drug metabolism activities of C3A--a human hepatocyte cell line--by tissue engineering within alginate scaffolds.
    Elkayam T; Amitay-Shaprut S; Dvir-Ginzberg M; Harel T; Cohen S
    Tissue Eng; 2006 May; 12(5):1357-68. PubMed ID: 16771648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three-dimensional co-culture of human hepatocytes and mesenchymal stem cells: improved functionality in long-term bioreactor cultures.
    Rebelo SP; Costa R; Silva MM; Marcelino P; Brito C; Alves PM
    J Tissue Eng Regen Med; 2017 Jul; 11(7):2034-2045. PubMed ID: 26511086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic esterase activity is increased in hepatocyte-like cells derived from human embryonic stem cells using a 3D culture system.
    Choi YJ; Kim H; Kim JW; Yoon S; Park HJ
    Biotechnol Lett; 2018 May; 40(5):755-763. PubMed ID: 29464570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transplantation of RADA16-BDNF peptide scaffold with human umbilical cord mesenchymal stem cells forced with CXCR4 and activated astrocytes for repair of traumatic brain injury.
    Shi W; Huang CJ; Xu XD; Jin GH; Huang RQ; Huang JF; Chen YN; Ju SQ; Wang Y; Shi YW; Qin JB; Zhang YQ; Liu QQ; Wang XB; Zhang XH; Chen J
    Acta Biomater; 2016 Nov; 45():247-261. PubMed ID: 27592818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HepaRG microencapsulated spheroids in DMSO-free culture: novel culturing approaches for enhanced xenobiotic and biosynthetic metabolism.
    Rebelo SP; Costa R; Estrada M; Shevchenko V; Brito C; Alves PM
    Arch Toxicol; 2015 Aug; 89(8):1347-58. PubMed ID: 25107451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro.
    Lübberstedt M; Müller-Vieira U; Mayer M; Biemel KM; Knöspel F; Knobeloch D; Nüssler AK; Gerlach JC; Zeilinger K
    J Pharmacol Toxicol Methods; 2011; 63(1):59-68. PubMed ID: 20460162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of hepatocyte-like cells from human umbilical cord-derived mesenchymal stem cells by defined microRNAs.
    Zhou X; Cui L; Zhou X; Yang Q; Wang L; Guo G; Hou Y; Cai W; Han Z; Shi Y; Han Y
    J Cell Mol Med; 2017 May; 21(5):881-893. PubMed ID: 27874233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced hepatotoxicity assessment through encapsulated HepG2 spheroids in gelatin hydrogel matrices: Bridging the gap from 2D to 3D culture.
    Park SY; Koh WG; Lee HJ
    Eur J Pharm Biopharm; 2024 Sep; 202():114417. PubMed ID: 39013493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptional, Functional, and Mechanistic Comparisons of Stem Cell-Derived Hepatocytes, HepaRG Cells, and Three-Dimensional Human Hepatocyte Spheroids as Predictive In Vitro Systems for Drug-Induced Liver Injury.
    Bell CC; Lauschke VM; Vorrink SU; Palmgren H; Duffin R; Andersson TB; Ingelman-Sundberg M
    Drug Metab Dispos; 2017 Apr; 45(4):419-429. PubMed ID: 28137721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluorometric assessment of acetaminophen-induced toxicity in rat hepatocyte spheroids seeded on micro-space cell culture plates.
    Sanoh S; Santoh M; Takagi M; Kanayama T; Sugihara K; Kotake Y; Ejiri Y; Horie T; Kitamura S; Ohta S
    Toxicol In Vitro; 2014 Sep; 28(6):1176-82. PubMed ID: 24878114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3D organotypic cultures of human HepaRG cells: a tool for in vitro toxicity studies.
    Gunness P; Mueller D; Shevchenko V; Heinzle E; Ingelman-Sundberg M; Noor F
    Toxicol Sci; 2013 May; 133(1):67-78. PubMed ID: 23377618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [SOX9 enhanced chondrogenic differentiation potential of human umbilical cord mesenchymal stem cells through cellular aggregation].
    Xu Y; Chen L; Shi Y; Gu Y; Zou J; Huang C; Tang TS
    Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(29):2050-4. PubMed ID: 23253807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic effects of hepatocyte growth factor-overexpressing human umbilical cord blood-derived mesenchymal stem cells on liver fibrosis in rats.
    Seo KW; Sohn SY; Bhang DH; Nam MJ; Lee HW; Youn HY
    Cell Biol Int; 2014 Jan; 38(1):106-16. PubMed ID: 24115681
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Zhang GZ; Sun HC; Zheng LB; Guo JB; Zhang XL
    World J Gastroenterol; 2017 Dec; 23(46):8152-8168. PubMed ID: 29290652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.